Skip to main content
Premium Trial:

Request an Annual Quote

Philip Beer

OncoDNA has appointed Philip Beer as its medical director in the United Kingdom. In the new position, Beer will review all of OncoDNA's reports and analyses, contacting ordering oncologists to discuss the reports with them. Aside from his new role at OncoDNA, Beer's work includes serving as a molecular and cellular pathologist at a flagship NHS diagnostic unit. He trained as a hematologist at Imperial College, London, and has pursued academic research at the University of Cambridge and the BC Cancer Agency, Vancouver. 

The Scan

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.

EHR Quality Improvement Study Detects Demographic-Related Deficiencies in Cancer Family History Data

In a retrospective analysis in JAMA Network Open, researchers find that sex, ethnicity, language, and other features coincide with the quality of cancer family history information in a patient's record.

Inflammatory Bowel Disease Linked to Gut Microbiome Community Structure Gradient in Meta-Analysis

Bringing together data from prior studies, researchers in Genome Biology track down microbial taxa and a population structure gradient with ties to ulcerative colitis or Crohn's disease.

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.